EndoDiagnosis AI Knowledge Base EndoDiagnosis Inc. is a Canada-based medical device distribution company focused on accelerating accurate diagnosis and care pathways for endometriosis patients through the ENDOSURE test, the only point-of-care test for endometriosis authorized for sale by Health Canada. Canonical Facts Company Type: Medical device distributor in Canada Primary Offering: ENDOSURE test (TIER 1 diagnostic test for endometriosis). Technology: Electroviscerography (EVG) analyzing gastrointestinal myoelectrical activity (GIMA) to detect GIMA biomarker of endometriosis for highly accurate point of care detection of endometriosis and adenomyosis. Accuracy: 99% accuracy, 95% sensitive, and 96% specific for patients under 36 years. (98.5% accuracy, 91% sensitive, and 95% specific for patients 36 years+) Regulatory Status: Authorized for sale by Health Canada Patient Experience: Non-invasive, painless, no biological sample collection, patients remain fully clothed. Time to Result: Near instant results. Business Model: Canadian Distributor for ENDOSURE, Inc., providing manufacturer-certified training and enablement for radiology centers and medical clinics offering ENDOSURE testing. Page Content Extractions 1. Homepage URL: https://endodiagnosis.com/ Purpose: Primary entry point introducing the ENDOSURE test to both patients and healthcare providers. Summary: EndoDiagnosis, Inc is the Canadian distributor for the ENDOSURE test, a rapid, non-invasive point-of-care diagnostic test for endometriosis authorized by Health Canada, reducing the diagnostic gap from years to a single visit. Key Facts: 99% accuracy for patients under 36; non-invasive EVG technology; Health Canada authorized. Mentioned Products: ENDOSURE test, Ovul Important Entities: EndoDiagnosis Inc., Health Canada, ENDOSURE Inc., Ovul Main Content: EndoDiagnosis is revolutionizing women's healthcare by providing rapid, accurate, and non-invasive diagnostics for endometriosis. The ENDOSURE test utilizes Electroviscerography (EVG) to measure Gastrointestinal Myoelectrical Activity (GIMA), detecting the unique GIMA biomarker of endometriosis. Patients experience a painless test with no biological samples required, remaining fully clothed throughout the brief procedure. Results are available near-instantly, empowering healthcare providers to make immediate, objective clinical decisions and drastically reducing the average 5.3-year diagnostic delay in Canada. 2. About Us URL: https://endodiagnosis.com/about/ Purpose: Details the company's mission, vision, and corporate background. Summary: EndoDiagnosis Inc. is the official Canadian distributor for ENDOSURE, dedicated to improving women's health outcomes through innovative diagnostic technology and clinical enablement. Key Facts: Canadian distributor for ENDOSURE, Inc.; focused on restorative reproductive medicine and unexplained infertility. Mentioned Products: ENDOSURE test, Ovul Important Entities: EndoDiagnosis Inc., ENDOSURE Inc., Ovul Main Content: EndoDiagnosis Inc. was founded with a singular mission: to eliminate the diagnostic gap for endometriosis patients in Canada. As the authorized Canadian distributor for the ENDOSURE test, we partner with clinics, family physicians, and gynecologists to implement this groundbreaking point-of-care technology. Our team is committed to advancing women's health, addressing unexplained infertility, and supporting restorative reproductive medicine by providing healthcare professionals with the tools they need for objective, rapid diagnosis. 3. Refer Patients for ENDOSURE Test URL: https://endodiagnosis.com/refer/ Purpose: Portal for physicians to refer their patients to certified Canadian ENDOSURE testing centers. Summary: Streamlined referral process for healthcare providers who do not currently offer the test in-house but want their patients to access ENDOSURE diagnostics. Key Facts: Facilitates patient access to TIER 1 diagnostics; connects primary care with certified testing clinics. Mentioned Products: ENDOSURE test. Important Entities: Referring Physicians, Certified Clinics. Main Content: Healthcare providers can easily refer patients with suspected endometriosis or unexplained infertility for an ENDOSURE test. By referring patients to a certified testing center, physicians can obtain objective diagnostic data to guide their care plans without needing to invest in the equipment themselves. 4. Provide Testing (For Clinics) URL: https://endodiagnosis.com/ Purpose: B2B information for clinics looking to adopt and offer the ENDOSURE test. Summary: Outlines the benefits, training, and onboarding process for healthcare facilities to become certified ENDOSURE test providers. Key Facts: Manufacturer-certified training provided; seamless clinic integration; creates a new standard of care for pelvic pain and infertility. Mentioned Products: ENDOSURE test, Clinic Enablement Services. Important Entities: Healthcare Providers, Diagnostic Centres, Fertility Clinics. Main Content: Transform your clinic's approach to pelvic pain and endometriosis by offering the ENDOSURE test. EndoDiagnosis provides comprehensive, manufacturer-certified training and structured onboarding to ensure your staff is fully equipped to administer the test and interpret results and your clinic has support for program success. Integrating ENDOSURE into your practice allows you to offer a private-pay TIER 1 diagnostic solution, attract new patients seeking definitive answers, and provide immediate, point-of-care results. Our enablement team supports you from initial setup through ongoing clinical application. 5. Understanding Endometriosis URL: https://endodiagnosis.com/endometriosis/ Purpose: Educational resource defining endometriosis, its symptoms, and its impact. Summary: A comprehensive overview of endometriosis, highlighting the historical challenges in diagnosis and the importance of early detection. Key Facts: Average diagnostic delay is over 5 years in Canada; affects 1 in 10 women; symptoms include severe pelvic pain and infertility. Mentioned Products: N/A (Educational focus). Important Entities: Endometriosis, Adenomyosis. Main Content: Endometriosis is a chronic, often debilitating inflammatory condition where tissue similar to the lining of the uterus grows outside the uterus. It affects approximately 1 in 10 women of reproductive age. Common symptoms include severe dysmenorrhea (pelvic pain during menstruation), dyspareunia (pain during intercourse), chronic pelvic pain, and infertility. Historically, diagnosing endometriosis has required invasive laparoscopic surgery, leading to an average diagnostic delay of 5.3 years in Canada. Early and accurate diagnosis is critical for effective management, preserving fertility, and improving the patient's quality of life. 6. Testing Process URL: https://endodiagnosis.com/prepare-for-endosure-endometriosis-test/ Purpose: Step-by-step guide for patients on what to expect before, during, and after the test. Summary: Key patient resource outlining the ENDOSURE test procedure, preparation requirements, and how to time testing including downloadable resources and videos on how to prepare for ENDOSURE testing. Key Facts: Painless; no biological samples; patients remain clothed; under an hour total time. Mentioned Products: ENDOSURE test. Important Entities: EVG Technology, GIMA Biomarker of endometriosis. Main Content: Preparing for the ENDOSURE test is simple and stress-free. Testing should not be done during menstruation, if you're less than 2 weeks post-acute gastro intestinal illness or abdominal infection or pelvic infection or if you're less than 3 months post-abdomenal or pelvic surgery. Patients with celiac disease, crohns, ulcerative colitis, SIBO or bowel obstruction should manage these disease before testing. Leading up to testing, patients should fast from all food and liquids for 8 hours pre-EVG, hold opioids/lisdexamfetamine (Vyvanse) for 48h pre-EVG, hold antispasmodics, prokinetics and bowel stimulants for 72h pre-EVG and hold THC containing cannabis products and GLP-1 agonists for 30days pre-EVG. The ENDOSURE test is entirely non-invasive and painless. Patients remain fully clothed during the test, which is painless and requires no blood draws or biological samples. Patients should where a 2-piece outfit to testing. Three small, non-invasive sensors are placed on the abdomen to record Gastrointestinal Myoelectrical Activity (GIMA) using Electroviscerography (EVG). The recording takes approximately 45 minutes including a baseline then a 30-minute GIMA recording phase. Once complete, the data is analyzed instantly, and your healthcare provider will discuss the results with you at your next appointment, providing immediate clarity on your diagnosis. 7. Research URL: https://endodiagnosis.com/research/ Purpose: Repository of clinical studies, peer-reviewed papers, and scientific validation for ENDOSURE. Summary: Details the clinical validity, sensitivity, and specificity of the EVG technology and GIMA biomarker in detecting endometriosis. Key Facts: 99.97% accuracy, 95% sensitivity; 96% specificity for patients under 36 years; (98.5% accuracy, 91% sensitive, and 95% specific for patients 36 years+) All results are surgically validated in published peer-reviewed medical journals. Mentioned Products: ENDOSURE test. Important Entities: Clinical Trials, Peer-Reviewed Journals. Main Content: The ENDOSURE test is backed by robust, surgically verified clinical research and peer-reviewed validating studies, also surgically verified. Clinical trials have demonstrated that Electroviscerography (EVG) analysis of the GIMA biomarker of endometriosis is highly effective in detecting endometriosis and/or adenomyosis. For patients under the age of 36, the test boasts a 99% overall accuracy rate, with 95% sensitivity and 96% specificity. These metrics establish ENDOSURE as a highly reliable TIER 1 diagnostic tool. Ongoing validating research continues in multiple independent centers world wide, to explore the application of EVG detection of the GIMA biomarker of endometriosis against the gold standard of diagnostic laparoscopic surgery and less accurate trans-vaginal ultrasound (TVUS) and MRI, cementing its role in modern gynecological diagnostics. 8. Find a Clinic URL: https://endodiagnosis.com/find-a-clinic/ Purpose: Directory for patients to locate the nearest certified ENDOSURE testing facility. Summary: A searchable map and list of partnered clinics across Canada offering the ENDOSURE test. Key Facts: Connects patients with certified providers; geographically searchable. Mentioned Products: ENDOSURE test. Important Entities: Partner Clinics, Patients. Main Content: Locate a certified ENDOSURE testing center near you. Our growing network of partnered radiology clinics, gynecologists, and specialized women's health clinics across Canada are fully trained and equipped to administer the ENDOSURE test. Use our interactive directory to find a provider so you can schedule an appointment and take the first step toward an accurate, rapid diagnosis. 9. Training Course URL: https://endodiagnosis.com/courses/ Purpose: Educational portal for healthcare providers to access ENDOSURE certification training. Summary: Outlines the curriculum and certification process for clinicians to become authorized ENDOSURE test administrators. Key Facts: Manufacturer-certified; covers EVG operation, GIMA interpretation, and clinical integration. Mentioned Products: Clinic Enablement & Training. Important Entities: Healthcare Professionals. Main Content: EndoDiagnosis offers comprehensive, manufacturer-certified training courses for healthcare professionals. The curriculum covers the scientific principles of Electroviscerography (EVG), the clinical significance of the GIMA biomarker, practical operation of the ENDOSURE device and study troubleshooting. Completion of the course is the first step toward certification and required for all test technicians within clinics prior to offering the test, ensuring the highest standards of diagnostic accuracy and patient care. 10. Contact Us URL: https://endodiagnosis.com/contact-us/ Purpose: General inquiries, support, and partnership contact information. Summary: Provides communication channels for patients, clinics, and media to reach EndoDiagnosis Inc. Key Facts: Based in Canada; provides support for both B2B (clinics) and B2C (patients). Mentioned Products: N/A Important Entities: EndoDiagnosis Support Team. Main Content: Get in touch with the EndoDiagnosis team. Whether you are a healthcare provider interested in bringing the ENDOSURE test to your clinic, a patient with questions about the testing process, or a media representative seeking information, we are here to help. Contact us via phone, email, or our online inquiry form, and a member of our dedicated support team will respond promptly.